Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 69 entries
Sorted by: Best Match Show Resources per page
Clinics in general practice.

British medical journal

[No authors listed]
PMID: 974601
Br Med J. 1976 Oct 02;2(6039):774.
Free PMC Article

No abstract available.

Cite
Clinics in general practice. Br Med J. 1976;2(6039):774
(1976). Clinics in general practice. British medical journal, 2(6039), 774.
"Clinics in general practice." British medical journal vol. 2,6039 (1976): 774.
Clinics in general practice. Br Med J. 1976 Oct 02;2(6039):774. PMID: 974601; PMCID: PMC1688629.
Copy Download .nbib Format: NLM
Recent Advancements in Prognostic Factors of Epithelial Ovarian Carcinoma.

International scholarly research notices

Ezzati M, Abdullah A, Shariftabrizi A, Hou J, Kopf M, Stedman JK, Samuelson R, Shahabi S.
PMID: 27382614
Int Sch Res Notices. 2014 Oct 29;2014:953509. doi: 10.1155/2014/953509. eCollection 2014.

Ovarian cancer remains the most common cause of gynecologic cancer-related death among women in developed countries. Nevertheless, subgroups of ovarian cancer patients experience relatively longer survival. Efforts to identify prognostic factors that characterize such patients are ongoing, with investigational...

Cite
Ezzati M, Abdullah A, Shariftabrizi A, et al. Recent Advancements in Prognostic Factors of Epithelial Ovarian Carcinoma. Int Sch Res Notices. 2014;2014:953509doi: 10.1155/2014/953509.
Ezzati, M., Abdullah, A., Shariftabrizi, A., Hou, J., Kopf, M., Stedman, J. K., Samuelson, R., & Shahabi, S. (2014). Recent Advancements in Prognostic Factors of Epithelial Ovarian Carcinoma. International scholarly research notices, 2014953509. https://doi.org/10.1155/2014/953509
Ezzati, Mohammad, et al. "Recent Advancements in Prognostic Factors of Epithelial Ovarian Carcinoma." International scholarly research notices vol. 2014 (2014): 953509. doi: https://doi.org/10.1155/2014/953509
Ezzati M, Abdullah A, Shariftabrizi A, Hou J, Kopf M, Stedman JK, Samuelson R, Shahabi S. Recent Advancements in Prognostic Factors of Epithelial Ovarian Carcinoma. Int Sch Res Notices. 2014 Oct 29;2014:953509. doi: 10.1155/2014/953509. eCollection 2014. PMID: 27382614; PMCID: PMC4897239.
Copy Download .nbib Format: NLM
Anti-K1 (Kell) Antibody Expressed in Maternal Breastmilk: A Case Report of a Neonate with Multiple Intrauterine Transfusions and Postnatal Exposure to Kell Antibody in Maternal Breastmilk.

Case reports in pediatrics

DeMoss P, Asfour M, Hersey K.
PMID: 28357148
Case Rep Pediatr. 2017;2017:6927813. doi: 10.1155/2017/6927813. Epub 2017 Mar 05.

Hemolytic disease of the fetus and newborn is a common consideration in newborn medicine, especially among the jaundiced. Maternal breastmilk provides numerous benefits to the infant, including nutrition and immunologic factors. Here, we present an infant who received three...

Cite
DeMoss P, Asfour M, Hersey K. Anti-K1 (Kell) Antibody Expressed in Maternal Breastmilk: A Case Report of a Neonate with Multiple Intrauterine Transfusions and Postnatal Exposure to Kell Antibody in Maternal Breastmilk. Case Rep Pediatr. 2017;2017:6927813doi: 10.1155/2017/6927813.
DeMoss, P., Asfour, M., & Hersey, K. (2017). Anti-K1 (Kell) Antibody Expressed in Maternal Breastmilk: A Case Report of a Neonate with Multiple Intrauterine Transfusions and Postnatal Exposure to Kell Antibody in Maternal Breastmilk. Case reports in pediatrics, 20176927813. https://doi.org/10.1155/2017/6927813
DeMoss, Patrick, et al. "Anti-K1 (Kell) Antibody Expressed in Maternal Breastmilk: A Case Report of a Neonate with Multiple Intrauterine Transfusions and Postnatal Exposure to Kell Antibody in Maternal Breastmilk." Case reports in pediatrics vol. 2017 (2017): 6927813. doi: https://doi.org/10.1155/2017/6927813
DeMoss P, Asfour M, Hersey K. Anti-K1 (Kell) Antibody Expressed in Maternal Breastmilk: A Case Report of a Neonate with Multiple Intrauterine Transfusions and Postnatal Exposure to Kell Antibody in Maternal Breastmilk. Case Rep Pediatr. 2017;2017:6927813. doi: 10.1155/2017/6927813. Epub 2017 Mar 05. PMID: 28357148; PMCID: PMC5357519.
Copy Download .nbib Format: NLM
Alterations in normal canine platelets during storage in EDTA anticoagulated blood.

Veterinary clinical pathology

Wilkerson MJ, Shuman W.
PMID: 12024308
Vet Clin Pathol. 2001;30(3):107-113. doi: 10.1111/j.1939-165x.2001.tb00417.x.

Flow cytometric detection of platelet surface-associated IgG (PSAIgG) can be used to determine whether immunologic factors are contributing to thrombocytopenia in dogs. In vitro alterations in platelet activation and morphology, however, could impact the results of this test. The...

Cite
Wilkerson MJ, Shuman W. Alterations in normal canine platelets during storage in EDTA anticoagulated blood. Vet Clin Pathol. 2001;30(3):107-113doi: 10.1111/j.1939-165x.2001.tb00417.x.
Wilkerson, M. J., & Shuman, W. (2001). Alterations in normal canine platelets during storage in EDTA anticoagulated blood. Veterinary clinical pathology, 30(3), 107-113. https://doi.org/10.1111/j.1939-165x.2001.tb00417.x
Wilkerson, Melinda J., and Shuman, Wilma. "Alterations in normal canine platelets during storage in EDTA anticoagulated blood." Veterinary clinical pathology vol. 30,3 (2001): 107-113. doi: https://doi.org/10.1111/j.1939-165x.2001.tb00417.x
Wilkerson MJ, Shuman W. Alterations in normal canine platelets during storage in EDTA anticoagulated blood. Vet Clin Pathol. 2001;30(3):107-113. doi: 10.1111/j.1939-165x.2001.tb00417.x. PMID: 12024308.
Copy Download .nbib Format: NLM
Skin reactions after intramuscular injection of Botulinum toxin A: a rare side effect.

BMJ case reports

Brüggemann N, Dögnitz L, Harms L, Moser A, Hagenah J.
PMID: 21686551
BMJ Case Rep. 2009;2009. doi: 10.1136/bcr.09.2008.0942. Epub 2009 Feb 02.

The use of Botulinum toxin as a treatment for dystonia and other neurological conditions has been rapidly increasing over the past decade. In general, idiosyncratic adverse reactions to repeated injections of Botulinum toxin seem to be rare and were...

Cite
Brüggemann N, Dögnitz L, Harms L, et al. Skin reactions after intramuscular injection of Botulinum toxin A: a rare side effect. BMJ Case Rep. 2009;2009doi: 10.1136/bcr.09.2008.0942.
Brüggemann, N., Dögnitz, L., Harms, L., Moser, A., & Hagenah, J. (2009). Skin reactions after intramuscular injection of Botulinum toxin A: a rare side effect. BMJ case reports, 2009. https://doi.org/10.1136/bcr.09.2008.0942
Brüggemann, Norbert, et al. "Skin reactions after intramuscular injection of Botulinum toxin A: a rare side effect." BMJ case reports vol. 2009 (2009). doi: https://doi.org/10.1136/bcr.09.2008.0942
Brüggemann N, Dögnitz L, Harms L, Moser A, Hagenah J. Skin reactions after intramuscular injection of Botulinum toxin A: a rare side effect. BMJ Case Rep. 2009;2009. doi: 10.1136/bcr.09.2008.0942. Epub 2009 Feb 02. PMID: 21686551; PMCID: PMC3028521.
Copy Download .nbib Format: NLM
Uncovering the cause of ulcerative colitis.

JGH open : an open access journal of gastroenterology and hepatology

Roberts-Thomson IC, Bryant RV, Costello SP.
PMID: 31406918
JGH Open. 2019 Aug 06;3(4):274-276. doi: 10.1002/jgh3.12216. eCollection 2019 Aug.

The cause of ulcerative colitis still remains unclear. The most popular hypothesis is that colitis develops because of a complex interaction of genetic, microbial, environmental, and immunologic factors. This editorial summarizes the widely accepted hypothesis and comments on a...

Cite
Roberts-Thomson IC, Bryant RV, Costello SP. Uncovering the cause of ulcerative colitis. JGH Open. 2019;3(4):274-276doi: 10.1002/jgh3.12216.
Roberts-Thomson, I. C., Bryant, R. V., & Costello, S. P. (2019). Uncovering the cause of ulcerative colitis. JGH open : an open access journal of gastroenterology and hepatology, 3(4), 274-276. https://doi.org/10.1002/jgh3.12216
Roberts-Thomson, Ian C, et al. "Uncovering the cause of ulcerative colitis." JGH open : an open access journal of gastroenterology and hepatology vol. 3,4 (2019): 274-276. doi: https://doi.org/10.1002/jgh3.12216
Roberts-Thomson IC, Bryant RV, Costello SP. Uncovering the cause of ulcerative colitis. JGH Open. 2019 Aug 06;3(4):274-276. doi: 10.1002/jgh3.12216. eCollection 2019 Aug. PMID: 31406918; PMCID: PMC6684508.
Copy Download .nbib Format: NLM
On type 1 diabetes mellitus pathogenesis.

Endocrine connections

Paschou SA, Papadopoulou-Marketou N, Chrousos GP, Kanaka-Gantenbein C.
PMID: 29191919
Endocr Connect. 2018 Jan;7(1):R38-R46. doi: 10.1530/EC-17-0347. Epub 2017 Nov 30.

Type 1 diabetes mellitus (T1DM) results from the autoimmune destruction of β cells of the endocrine pancreas. Pathogenesis of T1DM is different from that of type 2 diabetes mellitus, where both insulin resistance and reduced secretion of insulin by...

Cite
Paschou SA, Papadopoulou-Marketou N, Chrousos GP, et al. On type 1 diabetes mellitus pathogenesis. Endocr Connect. 2017;7(1):R38-R46doi: 10.1530/EC-17-0347.
Paschou, S. A., Papadopoulou-Marketou, N., Chrousos, G. P., & Kanaka-Gantenbein, C. (2018). On type 1 diabetes mellitus pathogenesis. Endocrine connections, 7(1), R38-R46. https://doi.org/10.1530/EC-17-0347
Paschou, Stavroula A, et al. "On type 1 diabetes mellitus pathogenesis." Endocrine connections vol. 7,1 (2018): R38-R46. doi: https://doi.org/10.1530/EC-17-0347
Paschou SA, Papadopoulou-Marketou N, Chrousos GP, Kanaka-Gantenbein C. On type 1 diabetes mellitus pathogenesis. Endocr Connect. 2018 Jan;7(1):R38-R46. doi: 10.1530/EC-17-0347. Epub 2017 Nov 30. PMID: 29191919; PMCID: PMC5776665.
Copy Download .nbib Format: NLM
Comparing Serum and Salivary Levels of Vitamin D in Patients with Recurrent Aphthous Stomatitis and Healthy Individuals.

Journal of dentistry (Shiraz, Iran)

Bahramian A, Falsafi P, Abbasi T, Ghanizadeh M, Abedini M, Kavoosi F, Kouhsoltani M, Noorbakhsh F, Dabbaghi Tabriz F, Rajaeih S, Rezaei F.
PMID: 30680302
J Dent (Shiraz). 2018 Dec;19(4):295-300.

STATEMENT OF THE PROBLEM: Recurrent aphthous stomatitis (RAS) is the most prevalent ulcerative condition of the oral mucosa. Many studies have emphasized on immunologic factors as the reason of inducing RAS; however, the exact etiologic cause of RAS has...

Cite
Bahramian A, Falsafi P, Abbasi T, et al. Comparing Serum and Salivary Levels of Vitamin D in Patients with Recurrent Aphthous Stomatitis and Healthy Individuals. J Dent (Shiraz). 2018;19(4):295-300
Bahramian, A., Falsafi, P., Abbasi, T., Ghanizadeh, M., Abedini, M., Kavoosi, F., Kouhsoltani, M., Noorbakhsh, F., Dabbaghi Tabriz, F., Rajaeih, S., & Rezaei, F. (2018). Comparing Serum and Salivary Levels of Vitamin D in Patients with Recurrent Aphthous Stomatitis and Healthy Individuals. Journal of dentistry (Shiraz, Iran), 19(4), 295-300.
Bahramian, Ayla, et al. "Comparing Serum and Salivary Levels of Vitamin D in Patients with Recurrent Aphthous Stomatitis and Healthy Individuals." Journal of dentistry (Shiraz, Iran) vol. 19,4 (2018): 295-300.
Bahramian A, Falsafi P, Abbasi T, Ghanizadeh M, Abedini M, Kavoosi F, Kouhsoltani M, Noorbakhsh F, Dabbaghi Tabriz F, Rajaeih S, Rezaei F. Comparing Serum and Salivary Levels of Vitamin D in Patients with Recurrent Aphthous Stomatitis and Healthy Individuals. J Dent (Shiraz). 2018 Dec;19(4):295-300. PMID: 30680302; PMCID: PMC6338692.
Copy Download .nbib Format: NLM
Immunoglobulin G4 deficiency can be a new entity for primary recurrent miscarriage: Successful pregnancy in two cases after treatment with intravenous immunoglobulin.

Turkish journal of obstetrics and gynecology

Shakerian B, Moghtaderi M, Heidari N.
PMID: 32231861
Turk J Obstet Gynecol. 2019 Dec;16(4):274-277. doi: 10.4274/tjod.galenos.2019.02650. Epub 2020 Feb 28.

Recurrent miscarriage is one of the complications of pregnancy in which the potential role of immunologic factors has already been mentioned. Here, two young women with recurrent miscarriage were consulted in the infertility center. The diagnosis of immunoglobulin G4...

Cite
Shakerian B, Moghtaderi M, Heidari N. Immunoglobulin G4 deficiency can be a new entity for primary recurrent miscarriage: Successful pregnancy in two cases after treatment with intravenous immunoglobulin. Turk J Obstet Gynecol. 2020;16(4):274-277doi: 10.4274/tjod.galenos.2019.02650.
Shakerian, B., Moghtaderi, M., & Heidari, N. (2019). Immunoglobulin G4 deficiency can be a new entity for primary recurrent miscarriage: Successful pregnancy in two cases after treatment with intravenous immunoglobulin. Turkish journal of obstetrics and gynecology, 16(4), 274-277. https://doi.org/10.4274/tjod.galenos.2019.02650
Shakerian, Behzad, et al. "Immunoglobulin G4 deficiency can be a new entity for primary recurrent miscarriage: Successful pregnancy in two cases after treatment with intravenous immunoglobulin." Turkish journal of obstetrics and gynecology vol. 16,4 (2019): 274-277. doi: https://doi.org/10.4274/tjod.galenos.2019.02650
Shakerian B, Moghtaderi M, Heidari N. Immunoglobulin G4 deficiency can be a new entity for primary recurrent miscarriage: Successful pregnancy in two cases after treatment with intravenous immunoglobulin. Turk J Obstet Gynecol. 2019 Dec;16(4):274-277. doi: 10.4274/tjod.galenos.2019.02650. Epub 2020 Feb 28. PMID: 32231861; PMCID: PMC7090269.
Copy Download .nbib Format: NLM
Viral and Immunologic Factors Associated with Fatal Outcome of Patients with Severe Fever with Thrombocytopenia Syndrome in Korea.

Viruses

Kwon JS, Jin S, Kim JY, Ra SH, Kim T, Park SY, Kim MC, Park SY, Kim D, Cha HH, Lee HJ, Kim MJ, Chong YP, Lee SO, Choi SH, Kim YS, Lee KH, Kee SH, Kim SH.
PMID: 34960620
Viruses. 2021 Nov 23;13(12). doi: 10.3390/v13122351.

Significant progress has been made on the molecular biology of the severe fever with thrombopenia virus (SFTSV); however, many parts of the pathophysiological mechanisms of mortality in SFTS remain unclear. In this study, we investigated virologic and immunologic factors...

Cite
Kwon JS, Jin S, Kim JY, et al. Viral and Immunologic Factors Associated with Fatal Outcome of Patients with Severe Fever with Thrombocytopenia Syndrome in Korea. Viruses. 2021;13(12)doi: 10.3390/v13122351.
Kwon, J. S., Jin, S., Kim, J. Y., Ra, S. H., Kim, T., Park, S. Y., Kim, M. C., Park, S. Y., Kim, D., Cha, H. H., Lee, H. J., Kim, M. J., Chong, Y. P., Lee, S. O., Choi, S. H., Kim, Y. S., Lee, K. H., Kee, S. H., & Kim, S. H. (2021). Viral and Immunologic Factors Associated with Fatal Outcome of Patients with Severe Fever with Thrombocytopenia Syndrome in Korea. Viruses, 13(12), . https://doi.org/10.3390/v13122351
Kwon, Ji-Soo, et al. "Viral and Immunologic Factors Associated with Fatal Outcome of Patients with Severe Fever with Thrombocytopenia Syndrome in Korea." Viruses vol. 13,12 (2021). doi: https://doi.org/10.3390/v13122351
Kwon JS, Jin S, Kim JY, Ra SH, Kim T, Park SY, Kim MC, Park SY, Kim D, Cha HH, Lee HJ, Kim MJ, Chong YP, Lee SO, Choi SH, Kim YS, Lee KH, Kee SH, Kim SH. Viral and Immunologic Factors Associated with Fatal Outcome of Patients with Severe Fever with Thrombocytopenia Syndrome in Korea. Viruses. 2021 Nov 23;13(12). doi: 10.3390/v13122351. PMID: 34960620.
Copy Download .nbib Format: NLM
Identification and Validation of Prognostic Factors of Lipid Metabolism in Obstructive Sleep Apnea.

Frontiers in genetics

Peng L, Wang X, Bing D.
PMID: 34880901
Front Genet. 2021 Nov 22;12:747576. doi: 10.3389/fgene.2021.747576. eCollection 2021.

No abstract available.

Cite
Peng L, Wang X, Bing D. Identification and Validation of Prognostic Factors of Lipid Metabolism in Obstructive Sleep Apnea. Front Genet. 2021;12:747576doi: 10.3389/fgene.2021.747576.
Peng, L., Wang, X., & Bing, D. (2021). Identification and Validation of Prognostic Factors of Lipid Metabolism in Obstructive Sleep Apnea. Frontiers in genetics, 12747576. https://doi.org/10.3389/fgene.2021.747576
Peng, Lu, et al. "Identification and Validation of Prognostic Factors of Lipid Metabolism in Obstructive Sleep Apnea." Frontiers in genetics vol. 12 (2021): 747576. doi: https://doi.org/10.3389/fgene.2021.747576
Peng L, Wang X, Bing D. Identification and Validation of Prognostic Factors of Lipid Metabolism in Obstructive Sleep Apnea. Front Genet. 2021 Nov 22;12:747576. doi: 10.3389/fgene.2021.747576. eCollection 2021. PMID: 34880901; PMCID: PMC8645574.
Copy Download .nbib Format: NLM
Ovarian Cancer: Biomarkers and Targeted Therapy.

Biomedicines

Radu MR, Prădatu A, Duică F, Micu R, Creţoiu SM, Suciu N, Creţoiu D, Varlas VN, Rădoi VE.
PMID: 34207450
Biomedicines. 2021 Jun 18;9(6). doi: 10.3390/biomedicines9060693.

Ovarian cancer is one of the most common causes of death in women as survival is highly dependent on the stage of the disease. Ovarian cancer is typically diagnosed in the late stage due to the fact that in...

Cite
Radu MR, Prădatu A, Duică F, et al. Ovarian Cancer: Biomarkers and Targeted Therapy. Biomedicines. 2021;9(6)doi: 10.3390/biomedicines9060693.
Radu, M. R., Prădatu, A., Duică, F., Micu, R., Creţoiu, S. M., Suciu, N., Creţoiu, D., Varlas, V. N., & Rădoi, V. E. (2021). Ovarian Cancer: Biomarkers and Targeted Therapy. Biomedicines, 9(6), . https://doi.org/10.3390/biomedicines9060693
Radu, Mihaela Raluca, et al. "Ovarian Cancer: Biomarkers and Targeted Therapy." Biomedicines vol. 9,6 (2021). doi: https://doi.org/10.3390/biomedicines9060693
Radu MR, Prădatu A, Duică F, Micu R, Creţoiu SM, Suciu N, Creţoiu D, Varlas VN, Rădoi VE. Ovarian Cancer: Biomarkers and Targeted Therapy. Biomedicines. 2021 Jun 18;9(6). doi: 10.3390/biomedicines9060693. PMID: 34207450; PMCID: PMC8235073.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 69 entries